Thyrocare Technologies Limited has informed the Exchange for the allotment of 3,624 shares pursuant to the exercise of stock options under the Thyrocare Employee Stock Option Scheme.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has allotted 3,624 equity shares (face value Rs. 10 each) to employees who exercised their stock options under the Thyrocare Employee Stock Option Scheme. The allotment was approved by the Nomination & Remuneration Committee on March 2, 2026. Post this allotment, the company's total paid-up equity share capital stands at 15,91,65,315 shares amounting to Rs. 1,59,16,53,150. The newly issued shares will rank equally with existing equity shares, and the company is seeking listing and trading approval from NSE and BSE. This is a routine ESOS exercise with negligible impact on the overall share base.
This is a minor, routine ESOS allotment representing a negligible dilution of 0.00023% of the existing share capital. No material impact on shareholders or stock price is expected.